Quality of Life in Patients With Tongue Cancer After Surgical Treatment: A 12-Month Prospective Study.

cancer cancer stage flap function local oral quality of life surgical excision tongue tumor

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Feb 2022
Historique:
accepted: 22 02 2022
entrez: 29 3 2022
pubmed: 30 3 2022
medline: 30 3 2022
Statut: epublish

Résumé

Aim of the study The project assessed the quality of life in post-operative patients with tongue cancer at three-month intervals in the first year after the operation. Material and methods A longitudinal prospective cohort study was conducted in the oral and maxillofacial department of a large public general hospital in northern Greece. Fifty-six patients out of a total of 156 with oral cancer were chosen for the study, who completed distinct quality-of-life surveys (EORTC QLQ-C30, and QLQ Head & Neck Module FACT-G). Results Tumor size correlated negatively with various EORTC QLQ-C30 scores, such as role functioning (p = 0.004) and cognitive functioning (p = 0.007), in the third evaluation. Tumor size correlated positively with subscale problems such as social eating (p = 0.001) and weight loss (p = 0.004) in the QLQ Head & Neck Module. The role functioning subscale (p = 0.003), the pain subscale (p = 0.001), and the speech issues QLQ Head & Neck module subscale (p = 0.003) adversely correlated with cancer stage. Patients who received flap reconstruction significantly differed from those who did not, on the EORTC QLQ-C30 cognitive functioning (U = 139.0, p = 0.006), dyspnea (U = 391.5, p = 0.006), and diarrhea (U = 425.0, p = 0.007) subscales during the third evaluation. Differences were also found in the QLQ-H&N35 subscale of sticky saliva (U = 391.0, p = 0.006). Patients with flap reconstruction did not significantly differ from those with immediate closure after one year. Differences concerned the EORTC QLQ-C30 subscales of cognitive functioning, dyspnea, and diarrhea, and the QLQ Head & Neck Module subscale of sticky saliva on the third assessment. No statistically significant correlations were observed between tumor size and cancer stage in the fourth assessment, but the grade of cancer positively correlated with the EORTC QLQ-C30 subscale of constipation (p = 0.000). Conclusions Our study suggests that quality of life is impaired in patients with tongue cancer who have undergone surgical interventions, particularly within the first month post-operation. However, quality of life is fully restored one year after the surgical excision. Future studies should explore early interventions to help healthcare providers better treat this unique group of patients.

Identifiants

pubmed: 35345740
doi: 10.7759/cureus.22511
pmc: PMC8956482
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e22511

Informations de copyright

Copyright © 2022, Palitzika et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Int J Oral Maxillofac Surg. 2009 Feb;38(2):151-9
pubmed: 19135867
Support Care Cancer. 2018 Oct;26(10):3571-3578
pubmed: 29725798
Am J Clin Dermatol. 2001;2(4):239-51
pubmed: 11705251
Oral Oncol. 2007 Nov;43(10):1034-42
pubmed: 17307019
J Biochem Mol Toxicol. 2020 Oct;34(10):e22557
pubmed: 32583933
Clin Exp Otorhinolaryngol. 2019 May;12(2):107-144
pubmed: 30703871
J Prosthet Dent. 2018 Apr;119(4):663-670
pubmed: 28888409
Braz Oral Res. 2006 Oct-Dec;20(4):290-6
pubmed: 17242787
J Oral Maxillofac Surg. 2010 Sep;68(9):2164-8
pubmed: 20542366
Support Care Cancer. 2020 May;28(5):2071-2078
pubmed: 31900613
J Craniomaxillofac Surg. 2012 Jan;40(1):24-7
pubmed: 21514171
Oral Oncol. 2021 May;116:105249
pubmed: 33774501
Acta Otolaryngol. 2014 Oct;134(10):1086-93
pubmed: 25131390
Head Neck. 2011 Apr;33(4):458-68
pubmed: 20652979
J Oncol. 2020 Oct 10;2020:2920418
pubmed: 33101411
Clin Otolaryngol. 2005 Oct;30(5):428-37
pubmed: 16232247
Qual Life Res. 2010 Jun;19(5):761-8
pubmed: 20221806
J Cancer. 2021 Feb 22;12(8):2230-2242
pubmed: 33758601
Contemp Oncol (Pozn). 2020;24(2):112-117
pubmed: 32774136
Anticancer Res. 2012 Aug;32(8):3527-34
pubmed: 22843941
Medicine (Baltimore). 2019 Oct;98(41):e17431
pubmed: 31593097
Int J Cancer. 2001 Oct 1;94(1):135-9
pubmed: 11668488
ScientificWorldJournal. 2012;2012:842867
pubmed: 22919356
Cancer Med. 2021 Apr;10(8):2566-2578
pubmed: 33760398
Oral Oncol. 2020 Nov;110:104895
pubmed: 32653839
J Oncol. 2013;2013:756510
pubmed: 23533409
Acta Otorhinolaryngol Ital. 2008 Jun;28(3):120-5
pubmed: 18646573
Oral Oncol. 1999 Jan;35(1):27-32
pubmed: 10211307

Auteurs

Dimitra Palitzika (D)

Nursing, Papanikolaou Hospital, Thessaloniki, GRC.

Ioannis Tilaveridis (I)

Oral and Maxillofacial Surgery, Aristotle University of Thessaloniki, Thessaloniki, GRC.

Maria Lavdaniti (M)

Nursing, International Hellenic University, Thessaloniki, GRC.

Konstantinos Vahtsevanos (K)

Oral and Maxillofacial Surgery, Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.

Angeliki Kosintzi (A)

Special Education, Aristotle University of Thessaloniki, Thessaloniki, GRC.

Konstantinos Antoniades (K)

Oral and Maxillofacial Surgery, Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.

Classifications MeSH